Sign in

You're signed outSign in or to get full access.

HT

HALOZYME THERAPEUTICS (HALO)·Earnings Reports

Halozyme Q4 2025 business update — massive 2026 guidance raise, Surf Bio acquisition

Q4 2025

View earnings summary and analysis

Q3 2025

View earnings summary and analysis

Q2 2025

View earnings summary and analysis

Q1 2025

View earnings summary and analysis

Q4 2024

View earnings summary and analysis

Analyst Coverage

Research analysts covering HALOZYME THERAPEUTICS.

Recent News about HALOZYME THERAPEUTICS

Halozyme Raises 2026 Guidance to $1.8B, Hits $1B Royalty Milestone a Year Early
Corporate

Halozyme Raises 2026 Guidance to $1.8B, Hits $1B Royalty Milestone a Year Early

Jan 28
View all news